Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Muscodex | TABUK PHARMACEUTICAL MANUFACTURING CO. | Solution for injection | Jan 1, 2024 | Generic |
| Haemocomplettan P | CSL BEHRING | Powder for solution for injection/infusion | Jan 1, 2024 | Biological |
| Tavlesse | PATHEON INC | Film-coated tablet | Jan 1, 2024 | NCE |
| Bilvardi | Hainan Poly Pharm. Co., Ltd. | Powder for solution for injection/infusion | Jan 1, 2024 | Generic |
| Tavlesse | PATHEON INC | Film-coated tablet | Jan 1, 2024 | NCE |
| Revestive | Patheon Italia S.P.A. | Powder and solvent for solution for injection | Jan 1, 2024 | Biological |
| Sitavic | Jamjoom Pharmaceuticals Factory Company | Film-coated tablet | Jan 1, 2024 | Generic |
| Sapropterin Amarox | M/s Annora Pharma Private Limited | Tablet | Jan 1, 2024 | Generic |
| Paraxon | Jazeera Pharmaceutical Industries (JPI) | Capsule | Jan 1, 2024 | Generic |
| Matroda | DAR ALDAWA | Film-coated tablet | Jan 1, 2024 | Generic |
| Sitavic | Jamjoom Pharmaceuticals Factory Company | Film-coated tablet | Jan 1, 2024 | Generic |
| ROCLANDA | Aerie Pharmaceuticals Ireland Limited | Eye drops, solution | Jan 1, 2024 | NCE |
| Dopamine Hydrochloride in 5% Dextrose, 3200 mcg/ml | BAXTER HEALTHCARE CORPORATION | Solution for injection/infusion | Jan 1, 2024 | NCE |
| Siromune | M/s Annora Pharma Private Limited | Oral solution | Jan 1, 2024 | Generic |
| Mofecon-DR | Concord Biotech LTD | Prolonged-release tablet | Jan 1, 2024 | Generic |
| Posazox | Hetero Labs Limited Unit – III | Gastro-resistant tablet | Jan 1, 2024 | Generic |
| Normoten | Jazeera Pharmaceutical Industries (JPI) | Film-coated tablet | Jan 1, 2024 | Generic |
| Prestoprix Plus | Med city | Tablet | Jan 1, 2024 | Generic |
| Mofecon-DR | Concord Biotech LTD | Prolonged-release tablet | Jan 1, 2024 | Generic |
| Uridisitol | Hetero Labs Limited Unit – V | Film-coated tablet | Jan 1, 2024 | Generic |
